JP2018520182A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520182A5 JP2018520182A5 JP2018501348A JP2018501348A JP2018520182A5 JP 2018520182 A5 JP2018520182 A5 JP 2018520182A5 JP 2018501348 A JP2018501348 A JP 2018501348A JP 2018501348 A JP2018501348 A JP 2018501348A JP 2018520182 A5 JP2018520182 A5 JP 2018520182A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- carcinoma
- hydroxyvitamin
- breast
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562192505P | 2015-07-14 | 2015-07-14 | |
| US62/192,505 | 2015-07-14 | ||
| PCT/US2016/042202 WO2017011623A1 (en) | 2015-07-14 | 2016-07-14 | Transpapillary methods and compositions for treating breast disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018520182A JP2018520182A (ja) | 2018-07-26 |
| JP2018520182A5 true JP2018520182A5 (cg-RX-API-DMAC7.html) | 2019-08-29 |
Family
ID=57757662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018501348A Pending JP2018520182A (ja) | 2015-07-14 | 2016-07-14 | 乳房障害を処置するための経乳頭方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20180200206A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3322406A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2018520182A (cg-RX-API-DMAC7.html) |
| CN (1) | CN108024959A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016294526A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2992282A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017011623A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015109391A1 (en) | 2014-01-24 | 2015-07-30 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Smc combination therapy for the treatment of cancer |
| EP3283061A4 (en) * | 2015-04-14 | 2019-04-17 | Atossa Genetics Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST DISEASES AND ORGANISM-RELATED ILLNESSES |
| EP3679061A4 (en) * | 2017-09-06 | 2021-06-09 | University of Cincinnati | METHOD OF PREDICTING BREAST LESIONS IN EARLY STAGE |
| EP3681491A4 (en) | 2017-09-11 | 2021-06-30 | Atossa Therapeutics, Inc. | PROCESS FOR MANUFACTURING AND USE OF ENDOXIFES |
| CN110221068B (zh) * | 2018-03-02 | 2020-09-18 | 中国医学科学院基础医学研究所 | 检测Kyn含量的试剂的应用 |
| WO2021003433A1 (en) | 2019-07-03 | 2021-01-07 | Atossa Therapeutics, Inc. | Sustained release compositions of endoxifen |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6881548B2 (en) * | 1997-05-23 | 2005-04-19 | A&G Pharmaceutical, Inc. | Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| US6638727B1 (en) * | 1999-01-26 | 2003-10-28 | Cytyc Health Corporation | Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| US6398765B1 (en) * | 1999-03-01 | 2002-06-04 | Pro Duct Health, Inc. | Apparatus, methods and kits for simultaneous delivery of a substance to multiple breast milk ducts |
| US20020117169A1 (en) * | 2001-02-27 | 2002-08-29 | Kurz Daniel R. | Cover and applicator for a portion of a mammalian body |
| JP2004530659A (ja) * | 2001-02-28 | 2004-10-07 | ジャイルズ,ブライアン,シー. | 抗腫瘍および抗転移作用のための方法および処方 |
| DE60322191D1 (de) * | 2002-03-19 | 2008-08-28 | Cytyc Corp | Intraduktale behandlung von brustläsionen umfassend therapeutische und diagnostische mittel |
| US9808471B2 (en) * | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
| KR100419298B1 (ko) * | 2003-07-28 | 2004-02-18 | 조규학 | 부착형 브래지어 및 그 제조방법 |
| US7229420B2 (en) * | 2003-12-23 | 2007-06-12 | Cytyc Corporation | Medical instrument for accessing a breast duct for performing a medical procedure |
| US20050142315A1 (en) * | 2003-12-24 | 2005-06-30 | Desimone Joseph M. | Liquid perfluoropolymers and medical applications incorporating same |
| IL177006A0 (en) * | 2005-08-02 | 2006-12-10 | Veridex Llc | Predicting bone relapse of breast cancer |
| WO2007067773A2 (en) * | 2005-12-09 | 2007-06-14 | Mayo Foundation For Medical Education And Research | Assessing outcomes for breast cancer patients by determining cyp2d6 genotype |
| ES2539042T3 (es) * | 2006-06-02 | 2015-06-25 | Glaxosmithkline Biologicals S.A. | Procedimiento de identificación de si un paciente será respondedor o no a inmunoterapia |
| PT2101731T (pt) * | 2006-11-21 | 2018-04-18 | Jina Pharmaceuticals Inc | Endoxifeno para utilização no tratamento de cancro |
| CA2673870A1 (en) * | 2006-12-27 | 2008-07-10 | Emory University | Compositions and methods for the treatment of infections and tumors |
| WO2009105640A1 (en) * | 2008-02-22 | 2009-08-27 | Virginia Commonwealth University | Signatures associated with rejection or recurrence of cancer |
| WO2010008427A1 (en) * | 2008-04-11 | 2010-01-21 | Ludwig Institute For Cancer Research Ltd. | Tryptophan catabolism in cancer treatment and diagnosis |
| WO2009129352A2 (en) * | 2008-04-15 | 2009-10-22 | Windy Hill Medical | Device and method for accessing and treating ducts of mammary glands |
| WO2010009335A1 (en) * | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
| ES2624557T3 (es) * | 2008-12-11 | 2017-07-14 | Besins Healthcare Luxembourg Sarl | Composiciones farmacéuticas transdérmicas que comprenden un SERM |
| WO2011072244A1 (en) * | 2009-12-10 | 2011-06-16 | Mount Sinai School Of Medicine Of New York University | Method of treatment of breast cancer with tamoxifen |
| EP2425833A1 (de) * | 2010-09-03 | 2012-03-07 | Fresenius Kabi Deutschland GmbH | Die intravenöse Applikation von Fischöl/DHA +EPA vor bzw. mit Beginn der Chemotherapie |
| US20130045179A1 (en) * | 2011-08-15 | 2013-02-21 | Mihai Ciustea | Combination therapy and methods for treatment and prevention of hyperproliferative diseases |
| US9517183B2 (en) * | 2012-01-30 | 2016-12-13 | Patrick B. Ward | Nipple abrasion protector |
| WO2013134230A1 (en) * | 2012-03-05 | 2013-09-12 | Xavier University | Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer |
| US9220680B2 (en) * | 2012-07-13 | 2015-12-29 | South Dakota State University | Compositions and methods for localized drug delivery through mammary papillae |
| EP3092027A4 (en) * | 2014-01-10 | 2017-09-06 | Atossa Genetics Inc. | Transpapillary methods and compositions for diagnosing and treating breast conditions |
| EP3283061A4 (en) * | 2015-04-14 | 2019-04-17 | Atossa Genetics Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST DISEASES AND ORGANISM-RELATED ILLNESSES |
-
2016
- 2016-07-14 CA CA2992282A patent/CA2992282A1/en not_active Abandoned
- 2016-07-14 US US15/744,004 patent/US20180200206A1/en not_active Abandoned
- 2016-07-14 JP JP2018501348A patent/JP2018520182A/ja active Pending
- 2016-07-14 EP EP16825155.1A patent/EP3322406A4/en not_active Withdrawn
- 2016-07-14 AU AU2016294526A patent/AU2016294526A1/en not_active Abandoned
- 2016-07-14 WO PCT/US2016/042202 patent/WO2017011623A1/en not_active Ceased
- 2016-07-14 CN CN201680052914.XA patent/CN108024959A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11730736B2 (en) | Anticancer agents | |
| KR102566461B1 (ko) | 조합 요법 | |
| US20260137817A1 (en) | Combination cancer immunotherapy with pentaaza macrocyclic ring complex | |
| RS65214B1 (sr) | Modulatori integrisanog puta stresa | |
| US12414934B2 (en) | Combination therapies | |
| US12551581B2 (en) | Combination cancer immunotherapy with pentaaza macrocyclic ring complex | |
| RU2017104909A (ru) | Лечение рака комбинацией лучевой терапии, наночастиц оксида церия и химиотерапевтического средства | |
| SG174419A1 (en) | Methods of treatment using combination therapy | |
| JP2017516802A5 (cg-RX-API-DMAC7.html) | ||
| BR112020015520A2 (pt) | terapia de combinação para câncer com complexo de anel macrocíclico pentaaza e agente anticâncer à base de platina | |
| US9512138B2 (en) | Compositions and methods for treating cancer | |
| JP6422936B2 (ja) | 5−ブロモ−インジルビン | |
| US20160128988A1 (en) | Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor | |
| TWI837231B (zh) | 含有ezh1/2雙重抑制劑之醫藥組合及其用途 | |
| JP5694782B2 (ja) | 肺癌、腺癌及び他の病状のための治療方法及び組成物 | |
| CN111773388B (zh) | A-失碳-5α雄甾烷化合物类药物与抗癌药物的联合应用 | |
| EP4601643A1 (en) | Composition for treating paclitaxel-resistant breast cancer and method for preparation thereof | |
| HK40060452A (en) | COMBINED USE OF A-NOR-5α ANDROSTANE COMPOUND DRUG AND ANTICANCER DRUG |